Basic facts about the trial
The trial recruited 128 healthy volunteers aged 18–55, who were paid €1,900 (US$2,060) each.
Ninety people received different doses of the drug, and the remainder a placebo.
The trial had tested escalating single doses of the drug without observing any serious adverse side effects.